Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 601071, 11 pages
http://dx.doi.org/10.1155/2013/601071
Research Article

Protective Effects of Guava Pulp on Cholestatic Liver Injury

1National Hepatobiliary and Enteric Surgery Research Center, Xiangya Hospital of Central South University, 87 Xiangya Road, Changsha, Hunan 410008, China
2Surgery Department, School of Medicine, Complutense University, Madrid, Spain
3Department of Nutritional Science and Food Management, The College of Health Science, Ewha Womans University, Seoul, Republic of Korea
4Division of Gastroenterology and Liver Diseases, USC Research Center for Liver Diseases, Department of Medicine, Keck School of Medicine, USC, HMR Building, 415, 2011 Zonal Avenue, Los Angeles, CA 90033, USA

Received 5 August 2013; Accepted 5 September 2013

Academic Editors: S. DeMorrow, H. Denk, M. G. Mancino, and S. Pinlaor

Copyright © 2013 Jian Peng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Clavien, H. Petrowsky, M. L. DeOliveira, and R. Graf, “Strategies for safer liver surgery and partial liver transplantation,” The New England Journal of Medicine, vol. 356, no. 15, pp. 1545–1559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. K. Li and J. M. Crawford, “The pathology of cholestasis,” Seminars in Liver Disease, vol. 24, no. 1, pp. 21–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Schroeder, C. E. Marroquin, B. P. Bute, S. Khuri, W. G. Henderson, and P. C. Kuo, “Predictive indices of morbidity and mortality after liver resection,” Annals of Surgery, vol. 243, no. 3, pp. 373–379, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Yang, T. W. H. Li, K. S. Ko, M. Xia, and S. C. Lu, “Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes,” Hepatology, vol. 49, no. 3, pp. 860–870, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Yang, T. W. H. Li, J. Peng et al., “A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression,” Gastroenterology, vol. 141, no. 1, pp. 378–388, 2011. View at Google Scholar · View at Scopus
  6. P. K. Rai, S. Mehta, and G. Watal, “Hypolipidaemic & hepatoprotective effects of Psidium guajava raw fruit peel in experimental diabetes,” Indian Journal of Medical Research, vol. 131, no. 6, pp. 820–824, 2010. View at Google Scholar · View at Scopus
  7. A. C. Akinmoladun, E. M. Obuotor, and E. O. Farombi, “Evaluation of antioxidant and free radical scavenging capacities of some Nigerian indigenous medicinal plants,” Journal of Medicinal Food, vol. 13, no. 2, pp. 444–451, 2010. View at Google Scholar · View at Scopus
  8. C. Huang, M. Yin, and L. Chiu, “Antihyperglycemic and antioxidative potential of Psidium guajava fruit in streptozotocin-induced diabetic rats,” Food and Chemical Toxicology, vol. 49, no. 9, pp. 2189–2195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Choi, J. Hwang, S. Park et al., “Fermented guava leaf extract inhibits LPS-induced COX-2 and iNOS expression in Mouse macrophage cells by inhibition of transcription factor NF-κB,” Phytotherapy Research, vol. 22, no. 8, pp. 1030–1034, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Wehbe, R. Henson, F. Meng, J. Mize-Berge, and T. Patel, “Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression,” Cancer Research, vol. 66, no. 21, pp. 10517–10524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Kloek, H. A. Marsman, A. K. van Vliet, D. J. Gouma, and T. M. van Gulik, “Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver,” Surgery, vol. 144, no. 1, pp. 22–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Wuestefeld, C. Klein, K. L. Streetz et al., “Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice,” Hepatology, vol. 42, no. 5, pp. 1082–1090, 2005. View at Google Scholar
  13. A. A. M. El-Faramawy, L. B. E. El-Shazly, A. A. Abbass, and H. A. B. Ismail, “Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis,” Tropical Gastroenterology, vol. 32, no. 1, pp. 50–55, 2011. View at Google Scholar · View at Scopus
  14. S. B. DeMauro, L. E. Kilpatrick, J. S. Gerdes, and S. Abbasi, “Early inflammatory markers for prediction of cholestasis in very-low-birth-weight infants,” Neonatology, vol. 102, no. 3, pp. 229–234, 2012. View at Google Scholar
  15. Y. Shi, P. Frost, B. Hoang, A. Benavides, J. Gera, and A. Lichtenstein, “IL-6-induced enhancement of c-Myc translation in multiple myeloma cells: critical role of cytoplasmic localization of the RNA-binding protein hnRNP A1,” The Journal of Biological Chemistry, vol. 286, no. 1, pp. 67–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Nabata, S. Morimoto, E. Koh, T. Shiraishi, and T. Ogihara, “Interleukin-6 stimulates c-Myc expression and proliferation of cultured vascular smooth muscle cells,” Biochemistry International, vol. 20, no. 3, pp. 445–453, 1990. View at Google Scholar · View at Scopus
  17. P. Bontempo, A. Doto, M. Miceli et al., “Psidium guajava L. anti-neoplastic effects: Induction of apoptosis and cell differentiation,” Cell Proliferation, vol. 45, no. 1, pp. 22–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Georgiev, W. Jochum, S. Heinrich et al., “Characterization of time-related changes after experimental bile duct ligation,” British Journal of Surgery, vol. 95, no. 5, pp. 646–656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Yang, K. Ramani, M. Xia et al., “Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications,” Hepatology, vol. 49, no. 6, pp. 1982–1991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Quinn, Y. Ueno, H. Y. Pae et al., “Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 302, no. 1, pp. G182–G193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Francis, S. Glaser, Y. Ueno et al., “CAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway,” Journal of Hepatology, vol. 41, no. 4, pp. 528–537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Xia, H. Francis, S. Glaser, G. Alpini, and G. LeSage, “Bile acid interactions with cholangiocyte,” World Journal of Gastroenterology, vol. 12, no. 22, pp. 3553–3563, 2006. View at Google Scholar · View at Scopus
  23. J. S. Duncan, M. C. Whittle, K. Nakamura et al., “Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer,” Cell, vol. 149, no. 2, pp. 307–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Kawata, Y. Kobayashi, M. E. Gershwin, and C. L. Bowlus, “The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis,” Clinical Reviews in Allergy and Immunology, vol. 43, no. 3, pp. 230–241, 2012. View at Google Scholar
  25. J. J. W. Tischendorf, H. Hecker, M. Krüger, M. P. Manns, and P. N. Meier, “Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study,” American Journal of Gastroenterology, vol. 102, no. 1, pp. 107–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. E. Starzl, A. J. Demetris, and D. van Thiel, “Liver transplantation (first of two parts),” The New England Journal of Medicine, vol. 321, no. 15, pp. 1014–1022, 1989. View at Google Scholar · View at Scopus
  27. G. M. Hirschfield, E. J. Heathcote, and M. E. Gershwin, “Pathogenesis of cholestatic liver disease and therapeutic approaches,” Gastroenterology, vol. 139, no. 5, pp. 1481–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. J. Carey and K. D. Lindor, “Current pharmacotherapy for cholestatic liver disease,” Expert Opinion on Pharmacotherapy, vol. 13, no. 17, pp. 2473–2484, 2012. View at Google Scholar
  29. K. S. Ko, J. Peng, and H. Yang, “Animal models of cholangiocarcinoma,” Current Opinion in Gastroenterology, vol. 29, pp. 312–318, 2013. View at Google Scholar
  30. Y. Gong, Z. Huang, E. Christensen, and C. Gluud, “Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses,” American Journal of Gastroenterology, vol. 102, no. 8, pp. 1799–1807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. M. P. Gutiérrez, S. Mitchell, and R. V. Solis, “Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology,” Journal of Ethnopharmacology, vol. 117, no. 1, pp. 1–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. C. Aronson, J. de Haan, J. James et al., “Quantitative aspects of the parenchyma-stroma relationship in experimentally induced cholestasis,” Liver, vol. 8, no. 2, pp. 116–126, 1988. View at Google Scholar · View at Scopus
  33. M. Bauer and D. Schuppan, “TGFβ1 in liver fibrosis: time to change paradigms?” FEBS Letters, vol. 502, no. 1-2, pp. 1–3, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. K. R. Cutroneo, “How is type I procollagen synthesis regulated at the gene level during tissue fibrosis,” Journal of Cellular Biochemistry, vol. 90, no. 1, pp. 1–5, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Kwak, M. Park, H. Cho et al., “Transforming growth factor-β1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells,” Molecular Cancer Research, vol. 4, no. 3, pp. 209–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. B. L. Copple, H. Jaeschke, and C. D. Klaassen, “Oxidative stress and the pathogenesis of cholestasis,” Seminars in Liver Disease, vol. 30, no. 2, pp. 195–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Yongvanit, S. Pinlaor, and H. Bartsch, “Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis,” Parasitology International, vol. 61, no. 1, pp. 130–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Y. Lin and M. C. Yin, “Renal protective effects of extracts from guava fruit (Psidium guajava L.) in diabetic mice,” Plant Foods for Human Nutrition, vol. 67, no. 3, pp. 303–308, 2012. View at Google Scholar
  39. B. Janicke, C. Hegardt, M. Krogh et al., “The antiproliferative effect of dietary fiber phenolic compounds ferulic acid and p-coumaric acid on the cell cycle of Caco-2 cells,” Nutrition and Cancer, vol. 63, no. 4, pp. 611–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Luo, M. K. Daddysman, G. O. Rankin, B. Jiang, and Y. C. Chen, “Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc,” Cancer Cell International, vol. 10, article 16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Park and J. Choi, “Inhibition of β-catenin/Tcf signaling by flavonoids,” Journal of Cellular Biochemistry, vol. 110, no. 6, pp. 1376–1385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Chen, H. Zeng, Y. Guo et al., “MiRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc,” Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. B. van Breemen and N. Pajkovic, “Multitargeted therapy of cancer by lycopene,” Cancer Letters, vol. 269, no. 2, pp. 339–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Jordán, C. A. Margaría, P. E. Shaw, and K. L. Goodner, “Volatile components and aroma active compounds in aqueous essence and fresh pink guava fruit puree (Psidium guajava L.) by GC-MS and multidimensional GC/GC-O,” Journal of Agricultural and Food Chemistry, vol. 51, no. 5, pp. 1421–1426, 2003. View at Publisher · View at Google Scholar · View at Scopus